A2AR antagonist 1
CAS: 443103-97-7
Ref. 3D-TSA10397
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Información del producto
VIPadenant is a small molecule that has been developed to selectively inhibit the adenosine A2A receptor. It has the ability to modulate immune responses by inhibiting the production of pro-inflammatory cytokines and chemokines in Th17 cells, which are cells that play a role in autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. VIPadenant also inhibits lipase activity and blocks adenosine from binding to its receptors, which may lead to an increased metabolism of fat. The drug has shown an ability to inhibit cancer cell proliferation, and has been patented for use as a potential anti-cancer agent.
Propiedades químicas
Consulta técnica sobre: 3D-TSA10397 A2AR antagonist 1
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
